Glenmark Pharmaceuticals Reaches $7M Settlement in US Antitrust Lawsuits Over Cholesterol Drugs
Glenmark Pharmaceuticals has agreed to pay $7 million to settle antitrust lawsuits with three major healthcare entities - Humana, Centene, and Kaiser - over generic cholesterol medications Zetia and Vytorin.
© Copyright 2025. All Rights Reserved by MedPath